{"id":"W2029168581","doi":"10.1016/j.clgc.2013.09.002","title":"Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma","year":2013,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical endpoint; Oncology; Urothelial carcinoma; Internal medicine; Overall survival; Primary (astronomy); Urothelial cancer; Carcinoma; Second line; First line; Cancer; Clinical trial; Bladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001303908,0.001017358,0.00336084,0.00010774,0.0002723666,0.00004973504,0.001380367,0.0005624021,0.002045922],"category_scores_gemma":[0.0005902458,0.0004944724,0.002157474,0.0003877368,0.0003375541,0.0001155634,0.0005479062,0.001141723,0.0001477922],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004093046,"about_ca_system_score_gemma":0.005967082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003657091,"about_ca_topic_score_gemma":0.00006170502,"domain_scores_codex":[0.994199,0.000904976,0.001748546,0.001241086,0.001122747,0.0007836062],"domain_scores_gemma":[0.9937988,0.001814775,0.0008871056,0.00243112,0.0004088838,0.0006593063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006721841,0.0008983829,0.0001727758,0.002386541,0.001402615,0.00003956228,0.0001331918,0.000001862274,0.00002587303,0.000005453895,0.01747592,0.970736],"study_design_scores_gemma":[0.009012163,0.008136624,0.003686383,0.002850068,0.00248414,0.00003895847,0.00002608805,0.000004880776,0.0002508382,0.0002425006,0.9727343,0.000533077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03420721,0.9385182,0.00001874713,0.003075154,0.003713653,0.01754748,0.0009011645,0.0000701216,0.001948269],"genre_scores_gemma":[0.001646305,0.9691637,0.0004009604,0.002765054,0.006004072,0.006134432,0.0001281204,0.0002591339,0.01349826],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9702029,"threshold_uncertainty_score":0.9997507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1740494188975193,"score_gpt":0.4790419817274608,"score_spread":0.3049925628299415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}